Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.

Rojas C, Alt J, Ator NA, Wilmoth H, Rais R, Hin N, DeVivo M, Popiolek M, Tsukamoto T, Slusher BS.

J Psychopharmacol. 2016 Sep;30(9):887-95. doi: 10.1177/0269881116652586. Epub 2016 Jun 10.

PMID:
27287825
2.

D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.

Rojas C, Alt J, Ator NA, Thomas AG, Wu Y, Hin N, Wozniak K, Ferraris D, Rais R, Tsukamoto T, Slusher BS.

Neuropsychopharmacology. 2016 May;41(6):1610-9. doi: 10.1038/npp.2015.319. Epub 2015 Oct 16.

3.

Neurocognitive dysfunction and pharmacological intervention using guanfacine in a rhesus macaque model of self-injurious behavior.

Freeman ZT, Rice KA, Soto PL, Pate KA, Weed MR, Ator NA, DeLeon IG, Wong DF, Zhou Y, Mankowski JL, Zink MC, Adams RJ, Hutchinson EK.

Transl Psychiatry. 2015 May 19;5:e567. doi: 10.1038/tp.2015.61.

4.

Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].

Soto PL, Ator NA, Rallapalli SK, Biawat P, Clayton T, Cook JM, Weed MR.

Neuropsychopharmacology. 2013 Oct;38(11):2315-25. doi: 10.1038/npp.2013.137. Epub 2013 May 31. Erratum in: Neuropsychopharmacology. 2013 Nov;38(12):2553.

5.

A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations.

Soto PL, Dallery J, Ator NA, Katz BR.

Psychopharmacology (Berl). 2013 Aug;228(4):611-22. doi: 10.1007/s00213-013-3070-4. Epub 2013 Mar 26.

6.

Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons.

Goodwin AK, Mueller M, Shell CD, Ricaurte GA, Ator NA.

J Pharmacol Exp Ther. 2013 Jun;345(3):342-53. doi: 10.1124/jpet.113.203729. Epub 2013 Mar 20.

7.

Joseph Vincent Brady (1922-2011).

Hodos W, Gollub LR, Ator NA, Hursh SR.

Am Psychol. 2012 Dec;67(9):801. doi: 10.1037/a0030338.

PMID:
23276075
8.

Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.

Soto PL, Wilcox KM, Zhou Y, Kumar A, Ator NA, Riddle MA, Wong DF, Weed MR.

Neuropsychopharmacology. 2012 Nov;37(12):2566-79. doi: 10.1038/npp.2012.119. Epub 2012 Jul 18. Erratum in: Neuropsychopharmacology. 2013 May;38(6):1141. Kumar, Anil [added].

9.

GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons.

Vashchinkina E, Panhelainen A, Vekovischeva OY, Aitta-aho T, Ebert B, Ator NA, Korpi ER.

J Neurosci. 2012 Apr 11;32(15):5310-20. doi: 10.1523/JNEUROSCI.4697-11.2012.

10.

Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA.

J Pharmacol Exp Ther. 2011 Jul;338(1):310-7. doi: 10.1124/jpet.111.180612. Epub 2011 Apr 14.

11.

IACUC perspective on drug addiction research.

Nicholson KL, Ator NA.

ILAR J. 2011;52(3):379-85. doi: 10.1093/ilar.52.3.379. No abstract available.

PMID:
23382151
12.

Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons.

Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM.

Drug Alcohol Depend. 2011 Apr 1;114(2-3):217-24. doi: 10.1016/j.drugalcdep.2010.10.006. Epub 2010 Nov 26.

13.

Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.

Ator NA, Atack JR, Hargreaves RJ, Burns HD, Dawson GR.

J Pharmacol Exp Ther. 2010 Jan;332(1):4-16. doi: 10.1124/jpet.109.158303. Epub 2009 Sep 29.

14.

Consistent, high-level ethanol consumption in pig-tailed macaques via a multiple-session, limited-intake, oral self-dosing procedure.

Weed MR, Wilcox KM, Ator NA, Hienz RD.

Alcohol Clin Exp Res. 2008 Jun;32(6):942-51. doi: 10.1111/j.1530-0277.2008.00652.x. Epub 2008 Apr 26.

PMID:
18445107
15.
16.

Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques.

Weed MR, Carruth LM, Adams RJ, Ator NA, Hienz RD.

J Neuroimmune Pharmacol. 2006 Sep;1(3):250-9. Epub 2006 Jul 14.

PMID:
18040802
17.

Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.

Weerts EM, Ator NA, Kaminski BJ, Griffiths RR.

Eur J Pharmacol. 2005 Sep 5;519(1-2):103-13.

PMID:
16129429
18.

Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons.

Ator NA, Griffiths RR, Weerts EM.

Drug Alcohol Depend. 2005 May 9;78(2):113-23. Epub 2004 Dec 9.

PMID:
15845314
20.

Selectivity in generalization to GABAergic drugs in midazolam-trained baboons.

Ator NA.

Pharmacol Biochem Behav. 2003 May;75(2):435-45.

PMID:
12873636
21.

Principles of drug abuse liability assessment in laboratory animals.

Ator NA, Griffiths RR.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S55-72. Review.

PMID:
12759197
22.

Principles of initial experimental drug abuse liability assessment in humans.

Griffiths RR, Bigelow GE, Ator NA.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S41-54. Review.

PMID:
12759196
23.
24.

Behavioral and pharmacological variables affecting risky choice in rats.

Kaminski BJ, Ator NA.

J Exp Anal Behav. 2001 May;75(3):275-97.

25.

Drug discrimination: stimulus control during repeated testing in extinction.

Zarcone TJ, Ator NA.

J Exp Anal Behav. 2000 Nov;74(3):283-94.

26.

Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.

Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR.

Drug Alcohol Depend. 2000 Dec 22;61(1):69-84.

PMID:
11064185
27.
29.

Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons.

Weerts EM, Ator NA, Griffiths RR.

Drug Alcohol Depend. 1999 Nov 1;57(1):51-60.

PMID:
10617313
30.
31.
33.

Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.

Weerts EM, Ator NA, Grech DM, Griffiths RR.

J Pharmacol Exp Ther. 1998 Apr;285(1):41-53.

PMID:
9535993
35.
36.
37.
39.

A festschrift in honor of Joseph V. Brady in his 70th year.

Hodos W, Ator NA.

J Exp Anal Behav. 1994 Mar;61(2):131-4. No abstract available.

40.

Drug discrimination analysis of endogenous neuroactive steroids in rats.

Ator NA, Grant KA, Purdy RH, Paul SM, Griffiths RR.

Eur J Pharmacol. 1993 Sep 14;241(2-3):237-43.

PMID:
7902289
41.
42.

Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential.

Sannerud CA, Ator NA, Griffiths RR.

Psychopharmacol Ser. 1993;11:113-20. No abstract available.

PMID:
7908430
43.
44.

Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence.

Sannerud CA, Ator NA, Griffiths RR.

Behav Pharmacol. 1992 Oct;3(5):507-516.

PMID:
11224153
45.

Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.

Griffiths RR, Sannerud CA, Ator NA, Brady JV.

J Pharmacol Exp Ther. 1992 Mar;260(3):1199-208.

PMID:
1312162
46.
47.

Methocarbamol: evaluation of reinforcing and discriminative stimulus effects.

Sannerud CA, Ator NA, Griffiths RR.

Behav Pharmacol. 1991 Apr;2(2):143-150.

PMID:
11224058
48.

Discriminative stimulus effects of the novel anxiolytic buspirone.

Ator NA.

Behav Pharmacol. 1991 Feb;2(1):3-14.

PMID:
11224042
49.

Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.

Giffiths RR, Sannerud CA, Lamb RJ, Ator NA, Brady JV.

NIDA Res Monogr. 1990;105:329. No abstract available.

PMID:
1678867
50.

The discriminative stimulus effects of abecarnil.

Ator NA, Griffiths RR.

NIDA Res Monogr. 1990;105:325. No abstract available.

PMID:
1678865

Supplemental Content

Support Center